Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 3759 | 690 | 34.5 | 64% |
Classes in level above (level 3) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 588 | 12909 | HUNTINGTONS DISEASE//POLYGLUTAMINE//HUNTINGTIN |
Classes in level below (level 1) |
| ID, lev. below | Publications | Label for level below |
|---|---|---|
| 22085 | 337 | RKIP//RAF KINASE INHIBITOR PROTEIN//HIPPOCAMPAL CHOLINERGIC NEUROSTIMULATING PEPTIDE |
| 29113 | 157 | NEURONAL INTRANUCLEAR INCLUSION DISEASE//INTRANUCLEAR INCLUSION BODY DISEASE//NEURONAL INTRANUCLEAR HYALINE INCLUSION DISEASE |
| 31115 | 128 | MINOR VEIN//PARACRYSTALLINE STRUCTURES//PROTOPHLOEM SIEVE ELEMENT |
| 34575 | 68 | HIRANO BODIES//HIRANO BODY//INTRANEURONAL INCLUSIONS |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | RKIP | Author keyword | 76 | 69% | 9% | 65 |
| 2 | RAF KINASE INHIBITOR PROTEIN | Author keyword | 64 | 88% | 4% | 30 |
| 3 | HIPPOCAMPAL CHOLINERGIC NEUROSTIMULATING PEPTIDE | Author keyword | 42 | 94% | 2% | 15 |
| 4 | PEBP | Author keyword | 21 | 73% | 2% | 16 |
| 5 | PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN | Author keyword | 16 | 58% | 3% | 19 |
| 6 | RAF KINASE INHIBITORY PROTEIN | Author keyword | 15 | 82% | 1% | 9 |
| 7 | HIPPOCAMPAL CHOLINERGIC NEUROSTIMULATING PEPTIDE PRECURSOR PROTEIN | Author keyword | 15 | 88% | 1% | 7 |
| 8 | HIRANO BODIES | Author keyword | 12 | 58% | 2% | 14 |
| 9 | RAF KINASE INHIBITOR PROTEIN RKIP | Author keyword | 12 | 86% | 1% | 6 |
| 10 | HCNP | Author keyword | 11 | 69% | 1% | 9 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | RKIP | 63 | 76% | 6% | 44 |
| 2 | PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN | 45 | 53% | 9% | 60 |
| 3 | KINASE INHIBITOR PROTEIN | 36 | 50% | 8% | 52 |
| 4 | 23 KDA PROTEIN | 23 | 69% | 3% | 20 |
| 5 | CHOLINERGIC NEUROSTIMULATING PEPTIDE | 20 | 63% | 3% | 20 |
| 6 | ROD LIKE STRUCTURES | 18 | 89% | 1% | 8 |
| 7 | 21 KDA PROTEIN | 14 | 53% | 3% | 19 |
| 8 | RAF KINASE INHIBITOR | 14 | 57% | 2% | 17 |
| 9 | HCNP | 13 | 80% | 1% | 8 |
| 10 | HPEBP4 | 8 | 100% | 1% | 5 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| RKIP: Much more than Raf Kinase inhibitory protein | 2013 | 16 | 178 | 58% |
| Raf kinase inhibitor protein (RKIP) in cancer | 2012 | 14 | 48 | 85% |
| Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor | 2008 | 71 | 48 | 67% |
| Raf kinase inhibitory protein (RKIP): A physiological regulator and future therapeutic target | 2008 | 59 | 109 | 56% |
| Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein | 2005 | 53 | 30 | 70% |
| Identification of novel metastasis suppressor signaling pathways for breast cancer | 2012 | 13 | 36 | 39% |
| Signaling crossroads: The function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction | 2008 | 59 | 101 | 44% |
| NEURONAL INTRANUCLEAR HYALINE INCLUSION DISEASE - REPORT OF A CASE AND REVIEW OF THE LITERATURE | 1990 | 25 | 11 | 100% |
| Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-kappa B/Snail/YY1/RKIP circuitry | 2011 | 26 | 60 | 27% |
| Raf kinase inhibitor protein: a prostate cancer metastasis suppressor gene | 2004 | 42 | 44 | 68% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | NEUROANAT CELL BIOL HISTOL | 2 | 26% | 0.7% | 5 |
| 2 | CANC BIOL BIOCHEM | 1 | 38% | 0.4% | 3 |
| 3 | MOL CH ERONE | 1 | 40% | 0.3% | 2 |
| 4 | BIOL CHEM MOL PHARMACOL BCMP | 1 | 50% | 0.1% | 1 |
| 5 | CARCINOGENESIS TARGETED THER Y | 1 | 50% | 0.1% | 1 |
| 6 | DIPARTIMENTO MORFOL UMANA SCI BIOMED CITTA STU | 1 | 50% | 0.1% | 1 |
| 7 | HEFEI MAT | 1 | 50% | 0.1% | 1 |
| 8 | L LIFE SCI | 1 | 50% | 0.1% | 1 |
| 9 | MEAS INC | 1 | 50% | 0.1% | 1 |
| 10 | MINIMUM INVAS SURG | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 2) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000015758 | EPITHELIAL MESENCHYMAL TRANSITION//EMT//SNAIL |
| 2 | 0.0000010162 | COFFIN LOWRY SYNDROME//ERK5//JNK |
| 3 | 0.0000009246 | HUNTINGTONS DISEASE//HUNTINGTIN//HUNTINGTON DISEASE |
| 4 | 0.0000008344 | SELF INCOMPATIBILITY//S RNASE//SEXUAL PLANT REPRODUCTION |
| 5 | 0.0000007766 | NM23//NUCLEOSIDE DIPHOSPHATE KINASE//ING4 |
| 6 | 0.0000007042 | HATCHING ENZYME//MEPRIN//ASTACIN FAMILY |
| 7 | 0.0000006724 | STARCH SYNTHESIS//ADP GLUCOSE PYROPHOSPHORYLASE//SUCROSE SYNTHASE |
| 8 | 0.0000005987 | AMYOTROPHIC LATERAL SCLEROSIS//SPINAL MUSCULAR ATROPHY//MOTOR NEURON DISEASE |
| 9 | 0.0000005710 | 14 3 3 PROTEINS//14 3 3 SIGMA//14 3 3 |
| 10 | 0.0000005591 | 2 5 HEXANEDIONE//NEUROFILAMENT//NEUROFILAMENTS |